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What is Extensively Drug-Resistant 
Tuberculosis (XDR TB)?
Extensively drug resistant TB (XDR TB) is a rare 
type of multidrug-resistant tuberculosis (MDR 
TB) that is resistant to isoniazid and rifampin, 
plus any fluoroquinolone and at least one of 
three injectable second-line drugs (i.e., amikacin, 
kanamycin, or capreomycin). MDR TB is caused by 
an organism that is resistant to at least isoniazid 
and rifampin, the two most potent TB drugs.
How is XDR TB spread? 
Drug-susceptible TB and XDR TB are spread the 
same way. TB bacteria are put into the air when 
a person with TB disease of the lungs or throat 
coughs, sneezes, shouts, or sings. These bacteria 
can float in the air for several hours, depending 
on the environment. Persons who breathe 
in the air containing these TB bacteria can 
become infected. 
TB is not spread by
 • shaking someone’s hand 
 • sharing food or drink 
 • touching bed linens or toilet seats 
 • sharing toothbrushes 
 • kissing 
Why is XDR TB so serious?
Because XDR TB is resistant to the most potent 
TB drugs, the remaining treatment options are 
less effective, have more side effects, and are 
more expensive.  XDR TB is of special concern for 
persons with HIV infection or other conditions 
that can weaken the immune system. These 
persons are more likely to develop TB disease 
once they are infected, and they also have a 
higher risk of death if they develop TB disease.
Who is at risk for getting XDR TB?
Drug-resistant TB (MDR or XDR) is more common 
in people who:
 • Do not take their TB medicine regularly 
 • Do not take all of their TB medicines as 
prescribed by their doctor
 • Develop TB disease again, after having taken TB 
medicine in the past 
 • Come from areas of the world where drug-
resistant TB is common 
 • Have spent time with someone known to have 
drug-resistant TB disease 
How can I prevent myself from 
getting TB?
Avoid close contact for a prolonged period of 
time with known TB patients in crowded, enclosed 
environments like clinics, hospitals, prisons, or 
homeless shelters.
Can the TB vaccine (BCG) help prevent 
XDR TB?
The TB vaccine is called Bacille Calmette-Guérin 
(BCG), and it is used in many countries to prevent 
severe forms of TB in children. However, BCG is 
not generally recommended in the United States 
because it has limited effectiveness for preventing 
the most common forms of TB and in preventing 
TB in adults. The effect of BCG against XDR TB 
would likely be similar to the effect on drug-
susceptible TB.
If I have drug-susceptible TB, how can 
I prevent getting drug-resistant TB?
The most important thing is for you to continue 
taking all your TB medicines exactly as prescribed. 
No doses should be missed and treatment should 
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not be stopped early. You should tell your health 
care provider if you are having trouble taking the 
medications or if you have any side effects. If you 
plan to travel, talk with your health care provider, 
and make sure you have enough medicine to last 
while away.
Can XDR TB be treated and cured?
Yes, in some cases. Some TB control programs 
have shown that cure is possible for an estimated 
30% to 50% of affected people. Successful 
outcomes depend greatly on the extent of the 
drug resistance, the severity of the disease, 
whether the patient’s immune system is 
weakened, and adherence to treatment.
What are the symptoms of XDR TB?
The general symptoms of TB disease include 
feelings of sickness or weakness, weight loss, fever, 
and night sweats. The symptoms of TB disease of 
the lungs may also include coughing, chest pain, 
and coughing up blood. Symptoms of TB disease 
in other parts of the body depend on the area 
affected. If you have these symptoms, you should 
contact your doctor or local health department.
What should I do if I have been 
around someone who has XDR TB?
If you think you have been exposed to someone 
with XDR TB disease, you should contact your 
doctor or local health department about getting 
a TB skin test or blood test for TB infection. You 
should tell the doctor or nurse when you spent 
time with this person. You should also tell the 
doctor or nurse where the person with XDR TB is 
being treated. It will be important to know about 
this person’s treatment. If your test for TB infection 
is positive, you will need special follow up. 
How long does it take to find out if 
you have XDR TB?
If TB bacteria are found in the sputum (phlegm), 
the diagnosis of TB can be made in a day or two, 
but this finding will not be able to distinguish 
between drug-susceptible TB and drug-resistant 
TB. To determine drug susceptibility, the bacteria 
need to be grown and tested in a specialized 
laboratory. Final diagnosis for TB, and especially 
for XDR TB, may take from 6 to 16 weeks.
Is XDR TB a problem in the U.S?
The risk of acquiring XDR TB in the United States 
appears to be low because XDR TB is uncommon 
in the U.S. However, TB can spread easily. As long 
as XDR TB exists, the risk to people in the United 
States is not zero, and the U.S. public health 
system must address the threat.
How many cases of XDR TB have been 
reported in the U.S.?
In the United States, 63 cases of XDR TB have been 
reported between 1993 and 2011*.  
 
*The National Tuberculosis Surveillance System (NTSS) 1993-2011.
Is it safe to travel to countries where 
cases of XDR TB have been reported?
Although MDR and XDR TB are occurring globally, 
they are still rare. HIV-infected travelers are at 
greatest risk if they come in contact with a person 
with MDR or XDR TB.
All travelers should avoid high risk settings where 
there are no infection control measures in place. 
Documented places where transmission has 
occurred include crowded hospitals, prisons, 
homeless shelters, and other settings where 
susceptible persons come in contact with persons 
with TB disease.
What can health care providers do to 
prevent XDR TB?
Health care providers can help prevent MDR and 
XDR TB by quickly diagnosing TB cases, following 
recommended treatment guidelines, monitoring 
patients’ response to treatment, and making sure 
therapy is completed.
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Providers should also ensure proper 
implementation of infection control procedures 
to prevent exposure to TB in hospitals or health-
care settings where TB patients are likely to 
be seen.
Why does there seem to be more 
cases of XDR TB now than there were 
in the past? 
In 2006, CDC, the World Health Organization 
(WHO), and other global leaders in TB reported 
the results of a survey regarding drug-resistant 
TB conducted by 25 reference laboratories 
comprising the Global Supranational TB 
Reference Laboratory Network, the National TB 
Surveillance System in the United States, the 
national reference laboratory of South Korea, and 
the national MDR TB patient registry in Latvia.  
The findings indicated that 20% of M. tuberculosis 
isolates were MDR, and 2% also were resistant to 
many additional TB drugs.  This highly resistant 
form of TB was identified in every region of the 
world where there was lab capacity to identify it.  
In a report published in 2006, the highly resistant 
form of TB was named XDR TB.  Since then, more 
countries have improved their laboratory capacity 
to test for XDR TB and their ability to report 
XDR TB.  These factors have contributed to an 
apparent increase in drug-resistant TB because of 
better diagnosis and better reporting.
What is CDC doing to prevent TB 
from becoming a bigger problem 
both domestically and globally?
CDC is collaborating with other federal agencies 
and international partners to raise awareness 
and enhance strategies for TB prevention 
worldwide by: 
 • Strengthening TB services for people living 
with HIV/AIDS; 
 • Guiding preparedness and outbreak 
investigation responses;
 • Improving access to TB drugs; 
 • Conducting routine surveillance (including 
drug susceptibility) and periodic surveys;
 • Implementing new, rapid diagnostic tests;
 • Developing and promoting, national and 
international TB testing standards; 
 • Conducting program evaluation (e.g., National 
TB Indicators Project [NTIP]);
 • Building capacity of health care providers to 
diagnose and treat TB; 
 • Reinvigorating the Federal TB Task Force;
 • Providing assistance to improve TB program 
capacity in the U.S. and abroad; and
 • Developing education, risk, and media 
communications (Web- and print-based) to aid 
in preparedness and public awareness of TB 
prevention and control issues. 
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